LETTER TO THE EDITOR
Recurrence of renal cell carcinoma in a patient who underwent kidney transplantation after a 2-year, 5-month interval of partial nephrectomy: A case report
Ryunosuke Noda,
Corresponding Author
Ryunosuke Noda
Department of Nephrology, Japanese Red Cross Medical Center, Tokyo, Japan
Correspondence
Ryunosuke Noda, Department of Nephrology, Japanese Red Cross Medical Center, The address: 4-1-22 Hiro-o, Shibuya-Ku, Tokyo 150-8935, Japan.
Email: [email protected]
Search for more papers by this author Yoshitaka Ishibashi,
Yoshitaka Ishibashi
Department of Nephrology, Japanese Red Cross Medical Center, Tokyo, Japan
Search for more papers by this author Akira Ishikawa,
Akira Ishikawa
Department of Urology, Japanese Red Cross Medical Center, Tokyo, Japan
Search for more papers by this author
Ryunosuke Noda,
Corresponding Author
Ryunosuke Noda
Department of Nephrology, Japanese Red Cross Medical Center, Tokyo, Japan
Correspondence
Ryunosuke Noda, Department of Nephrology, Japanese Red Cross Medical Center, The address: 4-1-22 Hiro-o, Shibuya-Ku, Tokyo 150-8935, Japan.
Email: [email protected]
Search for more papers by this author Yoshitaka Ishibashi,
Yoshitaka Ishibashi
Department of Nephrology, Japanese Red Cross Medical Center, Tokyo, Japan
Search for more papers by this author Akira Ishikawa,
Akira Ishikawa
Department of Urology, Japanese Red Cross Medical Center, Tokyo, Japan
Search for more papers by this author
First published: 11 June 2022
No abstract is available for this article.
REFERENCES
- 1Frascà GM, Sandrini S, Cosmai L, Porta C, Asch W, Santoni M, et al. Renal cancer in kidney transplanted patients. J Nephrol. 2015; 28(6): 659–68.
- 2Israel P. Evaluation of transplant candidates with pre-existing malignancies. Ann Transpl. 1997; 2(4): 14–7.
- 3Knoll G, Cockfield S, Blydt-Hansen T, Baran D, Kiberd B, Landsberg D, et al. Canadian Society of Transplantation consensus guidelines on eligibility for kidney transplantation. CMAJ. 2005; 173(10): 1181–4.
- 4Al-Adra DP, Hammel L, Roberts J, et al. Pretransplant solid organ malignancy and organ transplant candidacy: a consensus expert opinion statement. Am J Transplant. 2021; 21(2): 460–74.